×
Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.
Cytokeratin 19 Antikörper (C-Term)
KRT19
Reaktivität: Human
WB, IHC (p), ICC
Wirt: Kaninchen
Polyclonal
unconjugated
Produktdetails anti-Cytokeratin 19 Antikörper
(ausblenden)
Target
Alle Cytokeratin 19 (KRT19) Antikörper anzeigen
Cytokeratin 19 (KRT19)
(Keratin 19 (KRT19))
Bindungsspezifität
Alle Epitope für Cytokeratin 19 Antikörper
C-Term
Reaktivität
Alle Reaktivitäten für Cytokeratin 19 Antikörper
Human
Wirt
Alle Wirte für Cytokeratin 19 Antikörper
Kaninchen
Klonalität
Alle Klonalitäten für Cytokeratin 19 Antikörper
Polyklonal
Konjugat
Alle Konjugate für Cytokeratin 19 Antikörper
Dieser Cytokeratin 19 Antikörper ist unkonjugiert
Applikation
Alle Applikationen für Cytokeratin 19 Antikörper
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunocytochemistry (ICC)
Kreuzreaktivität (Details)
No cross reactivity with other proteins.
Produktmerkmale
Rabbit IgG polyclonal antibody for Keratin, type I cytoskeletal 19 (KRT19) detection. Tested with WB, IHC-P, ICC in Human.
Immunogen
A synthetic peptide corresponding to a sequence at the C-terminal of human CK19.< br/>Immunogen was affinity purified.
Isotyp
IgG
Top Product
Discover our top product KRT19 Primärantikörper
Alternativen
(anzeigen)
Anwendungsinformationen
(ausblenden)
Beschränkungen
Nur für Forschungszwecke einsetzbar
Handhabung
(ausblenden)
Format
Lyophilized
Rekonstitution
Add 0.2 mL of distilled water will yield a concentration of 500 µg/mL.
Buffer
Each vial contains 5 mg BSA, 0.9 mg NaCl, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg Sodium azide.
Konservierungsmittel
Sodium azide, Thimerosal (Merthiolate)
Handhabung
Avoid repeated freezing and thawing.
Lagerung
-20 °C
Informationen zur Lagerung
At -20 °C for one year. After reconstitution, at 4 °C for one month. It can also be aliquotted and stored frozen at -20 °C for a longer time.
Referenzen für anti-Cytokeratin 19 Antikörper (ABIN965901)
(ausblenden)
Schweizer, Bowden, Coulombe, Langbein, Lane, Magin, Maltais, Omary, Parry, Rogers, Wright : "New consensus nomenclature for mammalian keratins. " in: The Journal of cell biology , Vol. 174 , Issue 2 , pp. 169-74 , (2006 ) (PubMed ).
Details zu Cytokeratin 19
(ausblenden)
Target
Cytokeratin 19 (KRT19)
(Keratin 19 (KRT19))
Andere Bezeichnung
Keratin, type I cytoskeletal 19 (KRT19 Produkte )
Synonyme
CK19 antikoerper, K19 antikoerper, K1CS antikoerper, AI663979 antikoerper, EndoC antikoerper, Krt-1.19 antikoerper, Krt1-19 antikoerper, Ka19 antikoerper, k19 antikoerper, ck19 antikoerper, k1cs antikoerper, krt9 antikoerper, krt15 antikoerper, MGC76282 antikoerper, GK-19 antikoerper, MGC83069 antikoerper, KRT19 antikoerper, keratin 19 antikoerper, keratin 19 L homeolog antikoerper, keratin, type I cytoskeletal 19 antikoerper, KRT19 antikoerper, Krt19 antikoerper, krt19 antikoerper, krt19.L antikoerper, LOC100344434 antikoerper, LOC101117946 antikoerper
Hintergrund
Keratin, type I cytoskeletal 19 is a protein that in humans is encoded by the KRT19 gene. The protein encoded by this gene is a member of the keratin family. It is specifically expressed in the periderm, the transiently superficial layer that envelops the developing epidermis. The type I cytokeratins are clustered in a region of chromosome 17q12-q21. Due to its high sensitivity, KRT19 is the most used marker for the RT-PCR-mediated detection of tumor cells disseminated in lymph nodes, peripheral blood, and bone marrow of breast cancer patients. Keratin 19 is often used together with keratin 8 and keratin 18 to differentiate cells of epithelial origin from hematopoietic cells in tests that enumerate circulating tumor cells in blood.
Zuletzt angesehen
(ausblenden)